IP Library Granted Patent US 10,051,846
Granted Patent B2
US 10,051,846 · App. 14/843,363 · Granted Aug 21, 2018

Methods, compositions and systems for production of recombinant spider silk polypeptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,051,846
App. No.
14/843,363
Granted
Aug 21, 2018
Kind
B2
Abstract

Disclosed are methods, compositions, and systems for transforming silkworms to produce spider silk and analogs of spider silk. In certain embodiments, the method may include inserting a DNA sequence coding for at least a portion of a spider silk fibroin polypeptide, or an analog of a spider silk fibroin polypeptide, positioned between at least a portion of the 5′ and 3′ ends of a silkworm fibroin gene to generate a fusion gene construct having a sequence that encodes for a polypeptide comprising both spider silk fibroin and silkworm silk fibroin sequences. In certain embodiments, the fused gene is able to replace a native gene present in the silkworm such that the transformed silkworm expresses a polypeptide comprising a spider silk fibroin polypeptide, or an analog thereof, and expresses significantly less of the native silkworm silk.

Claims (15)

1. An isolated analog of a spider silk fibroin polypeptide, wherein the analog of the spider silk fibroin polypeptide is encoded by at least 2800 nucleotides encoding alternating beta-sheet domains and alpha-helix domains operably linked to a silkworm silk fibroin amino acid sequence, wherein the amino acid sequence of the beta-sheet domains are each at least 60% identical to at least one of the beta-sheet domains as set forth in SEQ ID NO: 2, and wherein the analog of the spider silk fibroin polypeptide is at least 50% stronger than native silkworm silk.

2. The isolated analog of the spider silk fibroin polypeptide of claim 1 , wherein the spider silk analog of the spider silk fibroin polypeptide comprises about 30 to 1000 spider silk beta-sheet domains alternating with about 30 to 1000 spider silk alpha helix domains.

3. The isolated analog of the spider silk fibroin polypeptide of claim 1 , wherein the analog of the spider silk fibroin polypeptide comprises an amino acid sequence as set forth in at least one of SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, or SEQ ID NO: 41.

4. The isolated analog of the spider silk fibroin polypeptide of claim 1 , wherein the analog of the spider silk fibroin polypeptide further comprises a reporter polypeptide.

5. The isolated analog of the spider silk fibroin polypeptide of claim 1 , wherein the analog of the spider silk fibroin polypeptide is at least 40% more elastic than native silkworm silk.

6. An isolated nucleic acid that encodes an analog of a spider silk fibroin polypeptide, wherein the nucleic acid comprises at least 2800 nucleotides encoding alternating beta-sheet domains and alpha-helix domains operably linked to a silkworm silk fibroin nucleic acid sequence, wherein the amino acid sequence of the beta-sheet domains are each at least 60% identical to at least one of the beta-sheet domains as set forth in SEQ ID NO: 2, and wherein the analog of the spider silk fibroin polypeptide is at least 50% stronger than native silkworm silk.

7. The isolated nucleic acid of claim 6 , wherein the amino acid sequence of the beta-sheet domains each have at least 60% identity to at least one of the beta-sheet domains encoded by the DNA sequence of SEQ ID NO: 34.

8. The isolated nucleic acid of claim 6 , having the sequence as set forth in SEQ ID NO: 34.

9. An isolated nucleic acid that encodes a spider silk fibroin polypeptide or an analog of a spider silk fibroin polypeptide, operably linked to at least one silkworm fibroin nucleic acid sequence.

10. The isolated nucleic acid of claim 9 , wherein the at least one silkworm nucleic acid sequence comprises a 5′ end of a native silkworm fibroin gene, a 3′ end of a native silkworm fibroin gene, or both a 5′ end of a native silkworm fibroin gene and a 3′ end of a native silkworm fibroin gene.

11. The isolated nucleic acid of claim 9 , wherein the analog of the spider silk fibroin polypeptide is encoded by a nucleic acid sequence comprising at least 2800 nucleotides encoding alternating beta-sheet domains and alpha-helix domains, wherein the amino acid sequence of the beta-sheet domains are each at least 60% identical to at least one of the beta-sheet domains as set forth in SEQ ID NO: 2, and wherein the analog of the spider silk fibroin polypeptide is at least 50% stronger than native silkworm silk.

12. The isolated nucleic acid of claim 10 , wherein the silkworm fibroin gene 5′ end comprises a nucleic acid sequence as set forth in at least one of SEQ ID NOs: 5, 10, 15, or 20.

13. The isolated nucleic acid of claim 10 , wherein the silkworm fibroin gene 3′ end comprises a nucleic acid sequence as set forth in at least one of SEQ ID NOs: 8, 13, 18, or 22.

14. A transgenic silkworm transformed with an isolated nucleic acid that encodes a spider silk fibroin polypeptide or an analog of a spider silk fibroin polypeptide, wherein the analog of the spider silk fibroin polypeptide is encoded by at least 2800 nucleotides encoding alternating beta-sheet domains and alpha-helix domains, wherein the amino acid sequence of the beta-sheet domains are each at least 60% identical to at least one of the beta-sheet domains as set forth in SEQ ID NO: 2, and wherein the transgenic silkworm produces a silk that is at least 50% stronger than native silkworm silk.

15. A silk produced by the transgenic silkworm of claim 14 , wherein the silk is at least 50% stronger than native silkworm silk.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2020
From: BOGIN, ROBERT I.
To: EGI-LENDERS, LLC
Reel/Frame 054344/0426 →
TRANSFER AFTER FORECLOSURE ON SECURITY INTEREST Recorded Feb 1, 2019
From: NIEDERMAYER, ROY I., MR.
To: BOGIN, ROBERT, MR.
Reel/Frame 048207/0739 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2017
From: BRIGHAM, DAVID L.
To: ENTOGENETICS, INC.
Reel/Frame 043767/0473 →
SECURITY INTEREST Recorded Nov 23, 2015
From: ENTOGENETICS, INC.
To: EIG, WAYNE D.; EGI VENTURE LLC; FFI-WINTERFIELD, LLC; TWIN PRIME CONJECTURE LLC; NIEDERMAYER-ROSS INVESTMENT GROUP, LLC
Reel/Frame 037121/0961 →